238 related articles for article (PubMed ID: 19859962)
21. Aspects of spatial memory and behavioral disinhibition in Tg2576 transgenic mice as a model of Alzheimer's disease.
Ognibene E; Middei S; Daniele S; Adriani W; Ghirardi O; Caprioli A; Laviola G
Behav Brain Res; 2005 Jan; 156(2):225-32. PubMed ID: 15582108
[TBL] [Abstract][Full Text] [Related]
22. Early discrimination reversal learning impairment and preserved spatial learning in a longitudinal study of Tg2576 APPsw mice.
Zhuo JM; Prescott SL; Murray ME; Zhang HY; Baxter MG; Nicolle MM
Neurobiol Aging; 2007 Aug; 28(8):1248-57. PubMed ID: 16828204
[TBL] [Abstract][Full Text] [Related]
23. Animal models of degenerative neurological disease.
Cork LC; Kitt CA; Struble RG; Griffin JW; Price DL
Prog Clin Biol Res; 1987; 229():241-69. PubMed ID: 3601987
[TBL] [Abstract][Full Text] [Related]
24. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production.
Arendash GW; Schleif W; Rezai-Zadeh K; Jackson EK; Zacharia LC; Cracchiolo JR; Shippy D; Tan J
Neuroscience; 2006 Nov; 142(4):941-52. PubMed ID: 16938404
[TBL] [Abstract][Full Text] [Related]
25. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease.
Morgan D; Diamond DM; Gottschall PE; Ugen KE; Dickey C; Hardy J; Duff K; Jantzen P; DiCarlo G; Wilcock D; Connor K; Hatcher J; Hope C; Gordon M; Arendash GW
Nature; 2000 Dec 21-28; 408(6815):982-5. PubMed ID: 11140686
[TBL] [Abstract][Full Text] [Related]
26. Decreased acetylcholine release is correlated to memory impairment in the Tg2576 transgenic mouse model of Alzheimer's disease.
Watanabe T; Yamagata N; Takasaki K; Sano K; Hayakawa K; Katsurabayashi S; Egashira N; Mishima K; Iwasaki K; Fujiwara M
Brain Res; 2009 Jan; 1249():222-8. PubMed ID: 18996097
[TBL] [Abstract][Full Text] [Related]
27. Powerful beneficial effects of benfotiamine on cognitive impairment and beta-amyloid deposition in amyloid precursor protein/presenilin-1 transgenic mice.
Pan X; Gong N; Zhao J; Yu Z; Gu F; Chen J; Sun X; Zhao L; Yu M; Xu Z; Dong W; Qin Y; Fei G; Zhong C; Xu TL
Brain; 2010 May; 133(Pt 5):1342-51. PubMed ID: 20385653
[TBL] [Abstract][Full Text] [Related]
28. Age-progressing cognitive impairments and neuropathology in transgenic CRND8 mice.
Hyde LA; Kazdoba TM; Grilli M; Lozza G; Brusa R; Zhang Q; Wong GT; McCool MF; Zhang L; Parker EM; Higgins GA
Behav Brain Res; 2005 May; 160(2):344-55. PubMed ID: 15863231
[TBL] [Abstract][Full Text] [Related]
29. Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice--a model of familial Parkinson's disease.
Poon HF; Frasier M; Shreve N; Calabrese V; Wolozin B; Butterfield DA
Neurobiol Dis; 2005 Apr; 18(3):492-8. PubMed ID: 15755676
[TBL] [Abstract][Full Text] [Related]
30. What transgenic mice tell us about neurodegenerative disease.
Gurney ME
Bioessays; 2000 Mar; 22(3):297-304. PubMed ID: 10684590
[TBL] [Abstract][Full Text] [Related]
31. Molecular imaging of neurodegeneration by a novel cross-disease biomarker.
Shirvan A; Reshef A; Yogev-Falach M; Ziv I
Exp Neurol; 2009 Sep; 219(1):274-83. PubMed ID: 19500576
[TBL] [Abstract][Full Text] [Related]
32. Behavioral phenotyping of mouse models of neurodegeneration.
Dumont M
Methods Mol Biol; 2011; 793():229-37. PubMed ID: 21913104
[TBL] [Abstract][Full Text] [Related]
33. Genetic mouse models of neurodegenerative diseases.
Trancikova A; Ramonet D; Moore DJ
Prog Mol Biol Transl Sci; 2011; 100():419-82. PubMed ID: 21377633
[TBL] [Abstract][Full Text] [Related]
34. Anti-α-synuclein immunotherapy reduces α-synuclein propagation in the axon and degeneration in a combined viral vector and transgenic model of synucleinopathy.
Spencer B; Valera E; Rockenstein E; Overk C; Mante M; Adame A; Zago W; Seubert P; Barbour R; Schenk D; Games D; Rissman RA; Masliah E
Acta Neuropathol Commun; 2017 Jan; 5(1):7. PubMed ID: 28086964
[TBL] [Abstract][Full Text] [Related]
35. Towards unveiling the genetics of neurodegenerative diseases.
Lill CM; Bertram L
Semin Neurol; 2011 Nov; 31(5):531-41. PubMed ID: 22266890
[TBL] [Abstract][Full Text] [Related]
36. [Understanding clinical neuropsychology: a basic approach (2)degenerative disease].
Kobayakawa M
No Shinkei Geka; 2010 Jul; 38(7):675-81. PubMed ID: 20628196
[No Abstract] [Full Text] [Related]
37. S100A9 knockout decreases the memory impairment and neuropathology in crossbreed mice of Tg2576 and S100A9 knockout mice model.
Kim HJ; Chang KA; Ha TY; Kim J; Ha S; Shin KY; Moon C; Nacken W; Kim HS; Suh YH
PLoS One; 2014; 9(2):e88924. PubMed ID: 24586443
[TBL] [Abstract][Full Text] [Related]
38. An overview of the molecular mechanisms and novel roles of Nrf2 in neurodegenerative disorders.
Yang Y; Jiang S; Yan J; Li Y; Xin Z; Lin Y; Qu Y
Cytokine Growth Factor Rev; 2015 Feb; 26(1):47-57. PubMed ID: 25280871
[TBL] [Abstract][Full Text] [Related]
39. Anti-ATP synthase autoantibodies induce neuronal death by apoptosis and impair cognitive performance in C57BL/6J mice.
Berry A; Vacirca D; Capoccia S; Bellisario V; Malorni W; Ortona E; Cirulli F
J Alzheimers Dis; 2013; 33(2):317-21. PubMed ID: 22954670
[TBL] [Abstract][Full Text] [Related]
40. Role of Alcohol Drinking in Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis.
Peng B; Yang Q; B Joshi R; Liu Y; Akbar M; Song BJ; Zhou S; Wang X
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32230811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
